Both in Pharmaceuticals
MAIA Biotechnology vs RenovoRx
Over the past year MAIA returned −28.1% and RNXT returned +33.1%; their daily moves had a correlation of 0.09.
MAIA −28.1% RNXT +33.1%Growth of $1, one year, split-adjusted
| Metric | MAIA | RNXT |
|---|---|---|
| Price | $1.15 | $1.57 |
| Market cap | $71.0M | $70.9M |
| Today | −2.54% | +1.29% |
| 1 month | −13.5% | −6.0% |
| 6 months | −12.2% | +46.7% |
| Year to date | −24.8% | +86.9% |
| 1 year | −29.0% | +33.1% |
| Revenue growth (YoY) | — | +115.4% |
| Gross margin | — | 84.3% |
| Net margin | — | −320.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 35.9× |
| Net cash | $27.6M | $9.5M |
| Dividend yield | — | — |
| Volatility (60d) | 48.9% | 107.0% |
| Short % of float | 4.3% | 1.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).